Pilot of a general practice-led intervention to optimise National Bowel Cancer Screening Program (NBCSP) participation.

Not Applicable

• Conditions: Colorectal cancer screening; Cancer - Bowel - Back passage (rectum) or large bowel (colon)

• Registration Number: ACTRN12623000355673
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-04-05
• Last Update Posted: 23 October 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

General Practices inclusion criteria:
•Has at least two GPs (FTE) willing to participate in the trial
•Nominated Practice Champion who is willing and able to liaise with the Daffodil Centre research team
•Uses Medical Director or Best Practice software
•Uses Pen CS, Polar or Primary Sense
•Available over the trial period May 2023 – June 2023
•Windows 10 or higher, i5/i7 16GB processing or willing to upgrade
•Has over 1000 active patients and sees minimum of 35 adult patients per day

Adult patient inclusion criteria:
Inclusion criteria
•General Practice patients aged 50 to 74 years

Exclusion Criteria

General Practice exclusion criteria:
•Shares server with another practice
•Uses paper-based medical records
•Does not share data with PHN

Adult patient exclusion criteria:
Exclusion criteria
•Under 50 or over 74 years
•Previous or current diagnosis of CRC
•Previous or current diagnosis of inflammatory bowel disease – e.g., ulcerative colitis or Chron’s disease
Familial syndrome associated with increased risk of CRC: lynch syndrome, familial adenomatous polyposis (FAP), attenuated FAP (AFAP), MUTYH-associated polyposis, polymerase proof-reading associated polyposis (PPAP), NTHL1-associated polyposis (NAP), Peutz-Jeghers syndrome, Juvenile polyposis syndrome, Serrated polyposis syndrome, and Cowden syndrome

Study & Design

• Study Type: Interventional
• Study Design: Not specified